| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-10-08 | NCT07865312 A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo | Phase 3 | Not Yet Recruiting |
| Phase 1 | 1 | |
| Phase 2 | 1 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07865312 | A Phase 3 Study of Povorcitinib Phosphate in Chinese Adults With Nonsegmental Vitiligo | NonSegmental Vitiligo | Not Yet Recruiting | 2026-10-08 |
| Phase 2/3 | ||||
| NCT07432854 | A Clinical Study Evaluating the Efficacy and Safety of CMS-D001 Tablets in the Treatment… | Moderate to Severe Plaque Psoriasis | Not Yet Recruiting | 2026-02-25 |
| Phase 2 | ||||
| NCT07465120 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to… | Moderate to Severe Atopic Dermatitis | Not Yet Recruiting | 2026-03-11 |
| Phase 1 | ||||
| NCT07790770 | A Phase I Clinical Trial to Evaluate CMS-F021 Following Single and Multiple Doses in… | Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria | Recruiting | 2026-08-27 |
Atopic Dermatitis (1) · Psoriasis (1)